Biogen (BIIB) Retained Earnings (2009 - 2026)

Biogen has reported Retained Earnings for 18 years, with the latest figure at $21.0 billion in Q2 2026.

• On a quarterly basis, Retained Earnings rose 4.15% year-over-year to $21.0 billion in Q2 2026; TTM through Jun 2026 was $21.0 billion, a 4.15% increase from a year earlier, with the FY2025 full-year figure at $20.6 billion, up 6.71% from the prior year.
• Retained Earnings was $21.0 billion for Q2 2026 at Biogen, roughly flat from $20.9 billion in the prior quarter.
• The five-year high for Retained Earnings was $21.0 billion in Q2 2026, with the low at -$172.8 million in Q2 2023.
• Average Retained Earnings over 5 years is $9.8 billion, with a median of $8.8 billion recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings plunged 56.52% in 2023, then jumped 13891.16% in 2025.
• Over 5 years, Retained Earnings stood at -$164.9 million in 2022, then soared by 10789.87% to $17.6 billion in 2023, then increased by 9.26% to $19.3 billion in 2024, then rose by 6.71% to $20.6 billion in 2025, then advanced by 2.03% to $21.0 billion in 2026.
• The last three Retained Earnings figures came in at $21.0 billion (Q2 2026), $20.9 billion (Q1 2026), and $20.6 billion (Q4 2025), per Business Quant data.